REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 27th, 2021 • Quotient LTD • In vitro & in vivo diagnostic substances
Contract Type FiledMay 27th, 2021 Company IndustryThis Agreement is being entered into pursuant to the Purchase Agreement, dated as of May 23, 2021, by and among the Company, the Guarantors party thereto (as defined therein), and the Buyers (as amended from time to time, the “Purchase Agreement”) in respect of the Company’s 4.75% Convertible Senior Notes due 2026 (the “Notes”), issued pursuant to the terms of the Indenture (as defined below).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 16th, 2021 • Gamida Cell Ltd. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 16th, 2021 Company IndustryThis Agreement is being entered into pursuant to the Note Purchase Agreement, dated as of February 15, 2021, by and among the Company, the Issuer, and the Buyers (as amended from time to time, the “Purchase Agreement”) in respect of the Issuer’s 5.875% Exchangeable Senior Notes due 2026 (the “Notes”), issued pursuant to the terms of the Indenture (as defined below).